KD

Kanad Das

Venture Partner at Bioluminescence Ventures

San Francisco, California

Overview

Work Experience

BV

Bioluminescence Ventures

  • Venture Partner

    2024 - Current

BM

Bristol Myers Squibb

  • Senior Director

    2023 - 2024

LT

Libra Therapeutics

  • Board Of Directors

    2021 - 2023

AT

Actym Therapeutics, Inc.

  • Board of Directors

    2020 - 2023

OT

OncoMyx Therapeutics

  • Board of Directors

    2019 - 2023

BI

Boehringer Ingelheim

  • Investment Director, Boehringer Ingelheim Venture Fund

    2018 - 2023

Sentien Biotechnologies, Inc.

  • Board of Directors

    2021 - 2021

M

Merck

  • Director, Business Development

    2015 - 2018

SU

Stanford University

  • Associate Director, SPARK Partnering and Alliance Management

    2012 - 2015

SPARK Program

  • Advisor

    2011 - 2012

Education

Investments

Actym Therapeutics, Inc.

Series A

Total Funding: $60M

Viron

Series A

Total Funding: $75M

Relevant Websites